Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le May MR, Russo JJ, Hibbert B. Mathew R, et al. Among authors: froeschl m. N Engl J Med. 2021 Aug 5;385(6):516-525. doi: 10.1056/NEJMoa2026845. N Engl J Med. 2021. PMID: 34347952 Clinical Trial.
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
Parlow S, Di Santo P, Mathew R, Jung RG, Simard T, Gillmore T, Mao B, Abdel-Razek O, Ramirez FD, Marbach JA, Dick A, Glover C, Russo JJ, Froeschl M, Labinaz M, Fernando SM, Hibbert B; CAPITAL DOREMI investigators. Parlow S, et al. Among authors: froeschl m. Eur Heart J Acute Cardiovasc Care. 2021 Oct 1;10(7):712-720. doi: 10.1093/ehjacc/zuab052. Eur Heart J Acute Cardiovasc Care. 2021. PMID: 34382063 Clinical Trial.
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Marbach JA, Di Santo P, Kapur NK, Thayer KL, Simard T, Jung RG, Parlow S, Abdel-Razek O, Fernando SM, Labinaz M, Froeschl M, Mathew R, Hibbert B. Marbach JA, et al. Among authors: froeschl m. J Am Heart Assoc. 2022 Mar 15;11(6):e023322. doi: 10.1161/JAHA.121.023322. Epub 2022 Mar 9. J Am Heart Assoc. 2022. PMID: 35261289 Free PMC article. Clinical Trial.
Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
Parlow S, Weng W, Di Santo P, Jung RG, Lepage-Ratte MF, Motazedian P, Prosperi-Porta G, Abdel-Razek O, Simard T, Chan V, Labinaz M, Froeschl M, Mathew R, Hibbert B; CAPITAL DOREMI Investigators. Parlow S, et al. Among authors: froeschl m. Can J Cardiol. 2022 Aug;38(8):1211-1219. doi: 10.1016/j.cjca.2022.04.004. Epub 2022 Apr 14. Can J Cardiol. 2022. PMID: 35430192 Clinical Trial.
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
Prosperi-Porta G, Motazedian P, Di Santo P, Jung RG, Parlow S, Abdel-Razek O, Simard T, Hutson J, Malhotra N, Fu A, Ramirez FD, Froeschl M, Mathew R, Hibbert B; CAPITAL DOREMI investigators. Prosperi-Porta G, et al. Among authors: froeschl m. J Cardiol. 2022 Oct;80(4):358-364. doi: 10.1016/j.jjcc.2022.06.001. Epub 2022 Jun 17. J Cardiol. 2022. PMID: 35725945 Free article. Clinical Trial.
Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation.
Jung RG, Abdel-Razek O, Di Santo P, Gillmore T, Stotts C, Makwana D, Soriano J, Moreland R, Verreault-Julien L, Goh CY, Parlow S, Sypkes C, Ramirez DF, Sadek M, Chan V, Toeg H, Simard T, Froeschl MPV, Labinaz M, Hibbert B. Jung RG, et al. Among authors: froeschl mpv. Open Heart. 2022 Sep;9(2):e002012. doi: 10.1136/openhrt-2022-002012. Open Heart. 2022. PMID: 36150746 Free PMC article.
In-hospital outcomes of STEMI patients on warfarin undergoing primary PCI.
Marbach JA, Almufleh A, Bernick J, Blondeau M, Osborne C, Russo J, Hibbert B, Froeschl M, Labinaz M, Glover C, Dick A, So D, Chong AY, Le May M. Marbach JA, et al. Among authors: froeschl m. Catheter Cardiovasc Interv. 2019 Jan 1;93(1):41-47. doi: 10.1002/ccd.27720. Epub 2018 Sep 30. Catheter Cardiovasc Interv. 2019. PMID: 30269392
Physician prediction of 1-year mortality in the cardiac catheterization laboratory: comparison to a validated risk score.
Sarathy K, Jung RG, Simard T, Parlow S, Di Santo P, Moreland R, Jung Y, Abdel-Razek O, Boland P, Russo JJ, Chong AY, So D, Froeschl M, Dick A, Glover C, Labinaz M, Le May M, Hibbert B. Sarathy K, et al. Among authors: froeschl m. Coron Artery Dis. 2021 Aug 1;32(5):403-410. doi: 10.1097/MCA.0000000000000967. Coron Artery Dis. 2021. PMID: 33060527
Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk.
Simard T, Jung RG, Di Santo P, Ramirez FD, Labinaz A, Gaudet C, Motazedian P, Parlow S, Joseph J, Moreland R, Marbach J, Boland P, Promislow S, Russo JJ, Chong AY, So D, Froeschl M, Le May M, Hibbert B. Simard T, et al. Among authors: froeschl m. Clin Transl Sci. 2021 Jan;14(1):354-361. doi: 10.1111/cts.12886. Epub 2020 Dec 2. Clin Transl Sci. 2021. PMID: 33264483 Free PMC article.
Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
Di Santo P, Simard T, Wells GA, Jung RG, Ramirez FD, Boland P, Marbach JA, Parlow S, Kyeremanteng K, Coyle D, Fergusson D, Russo JJ, Chong AY, Froeschl M, So DY, Dick A, Glover C, Labinaz M, Hibbert B, Le May M. Di Santo P, et al. Among authors: froeschl m. Circ Cardiovasc Interv. 2021 Mar;14(3):e009994. doi: 10.1161/CIRCINTERVENTIONS.120.009994. Epub 2021 Mar 9. Circ Cardiovasc Interv. 2021. PMID: 33685220
71 results